In addition to the aforementioned pathways, PAAD, PRAD and TNBC exhibited differentially expressed genes involved in the MAPK signaling pathway and PI3K-Akt signaling pathways; however, in COAD those pathways were relegated. This evidence concerns the gene AKT1 and prostate adenocarcinoma.